Shanghai INT Medical Instruments Co., Ltd. filed its monthly return for the period ended 31 May 2026, showing no movements in authorised or issued share capital during the month.

Total issued share capital remained at RMB 211.20 million, divided into 139.41 million H shares and 71.79 million domestic shares, all with a par value of RMB 1. Both categories recorded zero increases or reductions versus April.

The issuer held no treasury shares, and the total number of issued H shares and domestic shares was unchanged at 139.41 million and 71.79 million, respectively.

INT Medical confirmed compliance with Hong Kong Main Board Rule 13.32D(1), stating that the minimum 25% public-float requirement for its H shares is satisfied.

No share options, warrants, convertible securities, HDRs, or other equity-linked instruments were outstanding or issued in May. The board further certified full adherence to all listing rules and regulatory obligations associated with its capital structure.